Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calyxt, Inc. - Common Stock (NQ:CLXT)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Calyxt, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Calyxt's Return On Capital Employed Overview
According to Benzinga Pro data, during Q4, Calyxt (NASDAQ:CLXT) posted sales of $1.94 million. Earnings were up 3.42%, but Calyxt still reported an overall loss of $7.06 million.... 
Via Benzinga
Calyxt Posts 86% Decline In Q4 Revenue
Calyxt Inc (NASDAQ: CLXT) reported a fourth-quarter FY21 sales decline of 86% year-on-year, to $1.94 million, missing the consensus of $2.64 million. The revenue... 
Via Benzinga
Recap: Calyxt Q4 Earnings
Calyxt (NASDAQ:CLXT) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Calyxt beat... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Puma Biotechnology (NASDAQ:PBYI) ... 
Via Benzinga
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis... 
Via Benzinga
Preview: Calyxt's Earnings
Calyxt (NASDAQ:CLXT) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
Calyxt: Q2 Earnings Insights
Shares of Calyxt (NASDAQ:CLXT) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 36.36% over the past year to... 
Via Benzinga
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban... 
Via Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The company's market cap stands at $43.5 million.... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a... 
Via Benzinga
7 of the Best Penny Stocks Under $3 for 2022 to Buy Now
Penny stocks under $3 are full of potential and potential pitfalls. These are relatively safe and worth your consideration. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Qualigen Therapeutics (NASDAQ:QLGN 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock... 
Via Benzinga
15 Stocks Moving in Wednesday's Pre-Market Session
Gainers Acer Therapeutics Inc. (NASDAQ: ACER) rose 23.2% to $3.07 in pre-market trading. Acer Therapeutics and Relief Therapeutics reported the FDA acceptance for filing of New... 
Via Benzinga
Calyxt Seeks To Develop Palm Oil Alternative
Calyxt Inc (NASDAQ: CLXT) has entered into a research collaboration with a food ingredient manufacturer based in Asia to develop an improved soybean to produce oil... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Hepion Pharmaceuticals (NASDAQ:HEPA 
Via Benzinga
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 25.49% to $19.2 during Wednesday's pre-market session. The company's market cap stands at $242.7... 
Via Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported... 
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc,... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield... 
Via Benzinga
Looking into Calyxt's Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q2, Calyxt (NASDAQ:CLXT) posted sales of $11.88 million. Earnings were up 38.19%, but Calyxt still reported an overall... 
Via Benzinga
Calyxt Appoints Michael A. Carr As CEO
Biotechnology company Calyxt Inc (NASDAQ: CLXT) has appointed Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021. Carr will also serve as... 
Via Benzinga
55 Biggest Movers From Yesterday
Gainers Moving iMage Technologies, Inc. (NYSE: MITQ) shares jumped 700% to settle at $24.00 on Thursday. Moving iMage Technologies priced its initial public offering of 4.2... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock moved upwards by 78.94% to $3.06 during Thursday's regular session. The current volume of 158.9 million shares is... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.